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Background: Major depressive disorder is highly prevalent among Latinos with limited English language
proficiency in the United States. Although major depressive disorder is highly treatable, barriers to depression
treatment have historically prevented Latinos with limited English language proficiency from accessing effective
interventions. The project seeks to evaluate the efficacy of behavioral activation treatment for depression, an
empirically supported treatment for depression, as an intervention that may address some of the disparities
surrounding the receipt of efficacious mental health care for this population.
Methods/design: Following a pilot study of behavioral activation treatment for depression with 10 participants
which yielded very promising results, the current study is a randomized control trial testing behavioral activation
treatment for depression versus a supportive counseling treatment for depression. We are in the process of
recruiting 60 Latinos with limited English language proficiency meeting criteria for major depressive disorder
according to the Diagnostic and Statistical Manual of Mental Disorders 4th and 5th Edition for participation in a
single-center efficacy trial. Participants are randomized to receive 10 sessions of behavioral activation treatment for
depression (n = 30) or 10 sessions of supportive counseling (n = 30). Assessments occur prior to each session and at
1 month after completing treatment. Intervention targets include depressive symptomatology and the proposed
mechanisms of behavioral activation treatment for depression: activity level and environmental reward. We will also
examine other factors related to treatment outcome such as treatment adherence, treatment satisfaction, and
therapeutic alliance.
Discussion: This randomized controlled trial will allow us to determine the efficacy of behavioral activation
treatment for depression in a fast-growing, yet highly underserved population in US mental health services.
The study is also among the first to examine the effect of the proposed mechanisms of change of behavioral
activation treatment for depression (that is, activity level and environmental reward) on depression over time.
To our knowledge, this is the first randomized controlled trial to compare an empirical-supported treatment to a
control supportive counseling condition in a sample of depressed, Spanish-speaking Latinos in the United States.
Trial registration: Clinical Trials Register: NCT01958840; registered 8 October 2013.
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The lifetime prevalence rate of major depressive disorder
(MDD) in the general US population is approximately
16.6% [1]. Among Latinos in the US, MDD rates range
from 3% to 18% [2-4]. However, in primary care settings,
MDD rates are reportedly as high as 25% among Latinos
with limited English language proficiency (LEP) [5-8].
Considering that Latinos constitute the largest US mi-
nority group, and approximately 50% have LEP, elevated
rates of depression among Latinos with LEP represents a
great public health concern [9]. The strikingly high rates
of MDD among Latinos with LEP may stem from lan-
guage barriers that promote social isolation and limited
access to health care, which in turn result in distress and
low perceived self-efficacy [10,11]. Altogether, the ele-
vated rates of depression among Latinos with LEP and
the growing numbers of this population in the US point
to a pressing need for efficacious treatments for depres-
sion for this group.
Although MDD is generally highly treatable, many bar-
riers preclude Latinos with LEP from accessing quality
mental health care [12,13]. In general, less than 5% of
Latino immigrants afflicted with psychological disorders
seek mental health services from specialized practitioners
[14] due to a combination of linguistic and economic bar-
riers, cultural stigma, and the lack of empirically sup-
ported treatments for this population [13-15]. Moreover,
this group’s rates of treatment attrition are significantly
higher than for non-Latino White-Americans [16,17]. His-
torically, the aforementioned barriers have resulted in La-
tinos being underserved and under-represented in both
research and clinical trials.
Despite the barriers to receiving treatment, Latinos
with LEP tend to express positive attitudes towards psy-
chosocial treatments for depression [18,19]. This finding
is consistent with a valued belief among Latinos of doing
one’s part in one’s recovery (“poner de su parte”) rather
than relying on medication which is viewed as more pas-
sive [15,20,21]. The concept of poner de su parte is espe-
cially consistent with the framework of behavioral
psychotherapies [22]. In fact, earlier research regarded
behaviorally focused psychotherapies to be appropriate
treatments for Latinos with mental health needs [23].
Specifically, behavioral therapies may allow Latino cli-
ents to perceive control over everyday situations, in stark
contrast to the lack of control they experience resultant
from widespread socioeconomic marginalization, includ-
ing issues related to poverty and racism [23].
Support for behavioral treatments in Latinos was first
provided three decades ago [23]. In this study, group for-
mat behavioral therapy and group format cognitive ther-
apy demonstrated superior results relative to the wait-list
control group among Puerto Rican women. However, at a
5-week post-treatment follow-up assessment, treatmentgains were only maintained for those assigned to behav-
ioral therapy. More recently, behavioral activation (BA)
has been shown to be a promising form of behavior ther-
apy for Latinos with LEP. According to BA, depression re-
sults when constructive (that is, non-depressive) behaviors
are not positively reinforced. The depressive state is main-
tained by negative reinforcement, such as avoidance and
receiving sympathy from others [24]. Through BA, indi-
viduals engage in activities that are important and enjoy-
able to them [25]. Concurrently, participants are required
to monitor their mood while they engage in these activ-
ities. This increases their awareness of the effect that be-
haviors have over their mood [25,26]. To date, four
meta-analyses have revealed the effectiveness of the BA
approach [27-30]. Despite the empirical support of BA,
only two different open-label studies thus far have dem-
onstrated the promise of delivering BA in Latino popu-
lations [31,32].
The first open-trail pilot study (n = 10) evaluated a cul-
turally modified version of BA in Spanish [31] (modified
from [33]). In addition to scheduling pleasant activities,
this BA version incorporated cognitive rehearsal, skill
building, mindfulness, exposure to activities for which
avoidance is displayed, and role-playing. As part of the
cultural modifications, the investigators indicated simpli-
fying the treatment rationale and paying close attention
to values commonly attributed to Latinos that would affect
the course of treatment. Treatment outcomes suggested
significant decreases in depression severity in the intent-to-
treat sample. However, despite the promising results, only
three clients completed the 12-session treatment.
The second pilot study evaluated an alternative BA
version: the behavioral activation treatment for depres-
sion (BATD) [26,34]. BATD has been described as both
brief and efficient [35,36]. Furthermore, the ideographic
nature of BATD facilitates the incorporation of unique
personal values of individuals throughout treatment
which is especially important given the high degree of
within-group heterogeneity among Latinos [37]. In ran-
domized controlled trials (RCTs) with underserved mi-
nority samples facing similar problematic retention rates
and treatment access barriers as US Latinos, those who
were randomized to a BA were less likely to drop-out
relative to those assigned to treatment as usual [38-40].
Consistent with the efficiency of BATD, and its ability to
individualize treatment and promote treatment adher-
ence, we conducted an open-label trial (n = 10) using a
literal Spanish translation of the original BATD manual
without global cultural modifications. Across the treat-
ment course, depressive symptomatology decreased, and
the proposed BATD mechanisms (activity engagement
and environmental reward) increased. Further, activation
simultaneously corresponded with decreases in depres-
sion: as activation increased, depression decreased. On
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sive symptomatology. Results indicated sustained clinical
gains at the 1-month follow-up. Of note was that treat-
ment adherence and attendance were high in this small
sample; eight participants completed treatment. Taken
together, BA but especially BATD appears to be a prom-
ising depression treatment among Latinos with LEP.
The logical next step involves conducting an RCT.
Following up this promising initial work, the current
study is comprised of an RCT with three aims. First, we
will compare the impact of BATD and a supportive coun-
seling (SC) condition on participants’ depression through-
out the course of the study. We expect that participants
randomized to BATD will evidence greater reductions in
depressive symptoms and a higher percentage remission
of MDD relative to participants randomized to the SC
condition. Second, we will compare group differences on
the proposed mediators of BATD, including activation
and contact with environmental reward. We hypothesize
that participants assigned to the BATD condition will evi-
dence greater increases in activation and contact with en-
vironmental reward relative to those assigned to the SC
condition. We also expect that increases in activation and
contact with environmental reinforcement will correspond
with decreases in depression. Figure 1 is a depiction of
the models tested under this aim. Third, we will exam-
ine SC and BATD group differences on key conceptually
relevant variables associated with treatment retention
and outcomes in Latinos, such as treatment satisfaction
[41], therapeutic alliance [42], and perceived stigma
[43], as these variables have been shown to affect treat-
ment outcomes and retention in this population. In the
context of the third aim, we will compare dropout rates
between conditions. We expect that, relative to partici-
pants assigned to the SC condition, participants random-
ized to BATD will evidence higher treatment satisfaction
given the heavy emphasis of BATD on putting effort into
one’s recovery from depression ("poner de su parte"), a
treatment expectation highly valued in this population
[44,22]. Further, we hypothesize greater therapeutic alli-
ance in the BATD condition given the collaborative ap-
proach expected to emerge between the client and theFigure 1 Representation of models that will test the correspondence
reinforcement, and decreases in depression. Model 1 will test the simu
environmental reinforcement. Model 2 will test if increases in activation antherapist in this treatment condition [45]. We also
hypothesize that, as a result of the conceptualization of
depression of BATD as originating from the lack of en-
vironmental reinforcement, perceived stigma levels will
be lower relative to the SC condition. Finally, we expect
that treatment retention will be greater for the BATD
condition than for the SC condition based on previous
findings suggesting this trend [39,40].
Methods/design
Design
Sixty depressed Latinos with LEP from the community
will be randomized to receive individual BATD (n = 30)
or an individual contact time-matched SC condition (n =
30). The design allows for the examination of treatment
group differences in depression, activity level and contact
with environmental reinforcement, treatment adherence,
treatment satisfaction, therapeutic alliance, and perceived
stigma between conditions, consistent with our three
study aims. Assessments take place immediately prior to
each session and at 1-month post-treatment. This study
was approved by the University of Maryland-College
Park’s Institutional Review Board (protocol no. 403879–2).
We requested to obtain participants’ verbal informed
consent and not written informed consent to protect
the privacy and confidentiality of a sample that may be
represented predominantly by immigrant Latinos, who
may not be in the US on legal terms.
Recruitment
Participants are being recruited from the District of
Columbia Metro area, including Montgomery and Prince
George’s counties in Maryland. Most participants are con-
tacted through three different community organizations
that serve predominantly low-income Latinos with LEP.
Flyers are also posted in grocery stores, bus stops, public
libraries, community centers, and consulates serving
Latino populations.
Eligibility
Initial eligibility is determined via a telephone screener,
which includes questions from the Mood Disorders,between increases in activation and contact with environmental
ltaneous correspondence between depression with activation and
d contact with environmental reinforcement predict depression.
Figure 2 Flow diagram from recruitment to randomization.
BATD, behavioral activation treatment for depression; CoC; MDD,
major depressive disorder; SC, supportive counseling.
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modules of the Structured Clinical Interview for the
Diagnostic Statistical Manual version IV text revision
(SCID-IV) [46]. To be included in the study, participants
must: 1) be a minimum of 18 years of age; 2) be of Latino
descent; 3) self-report LEP; 4) meet current MDD criteria;
5) have completed the 4th grade of education or higher ei-
ther in their country of origin or in the US; 6) not have
current substance abuse or dependence; 7) have no bipo-
lar or psychotic disorders; 9) not be currently receiving
psychotherapy; and 10) if currently taking antidepressants,
demonstrate pharmacological stability as indicated by 3
or more consecutive months of use. Excluded individ-
uals are referred to mental health resources within the
community.
Procedure and randomization
After a participant is deemed eligible over the telephone,
they are scheduled for a first appointment at the Univer-
sity of Maryland, College Park. At the beginning of the
appointment, a research assistant reviews study proce-
dures, answers the participant’s questions about the
study, and obtains verbal informed consent. Along with
the verbal informed consent, participants are made
aware of the certificate of confidentiality obtained with
the purpose of protecting any identifiable information
and immigrant status from forced disclosure. Partici-
pants are also informed about randomization proce-
dures. Specifically, participants are told that they have
an equal chance of receiving one of two psychotherapies
that have yet to be formally evaluated among Latinos
with LEP. No details about the treatment content was
provided. After providing verbal informed consent, a
member of the staff trained in administering the SCID-
IV will administer the Mood Disorders, Substance Use
and Dependence, Psychotic Disorders, and Anxiety Dis-
order modules of the interview to confirm eligibility for
the study and characterize the sample’s psychopathology
appropriately.
Participants earn $15 for the completion of question-
naires at the baseline assessment and the post-treatment
assessment (corresponding to sessions 1 and 10 of treat-
ment). Participants are paid $10 for the remaining
scheduled assessment points. Participants are assessed
prior to each treatment session. In the situation that par-
ticipants do not qualify during the baseline interview,
they are paid for completing the baseline assessments. In
general, the completion of the assessments during the
first and last meetings take up to 70 minutes, and up to
20 minutes for the remaining meetings. After complet-
ing the assessments, participants receive compensation.
At the first meeting, a staff member not involved in the
study conducts the randomization using a computerized
random number generator and informs the participant’stherapist of the assigned therapy condition in person. The
research assistant conducting assessments for a partici-
pant is blind to every participants’ assigned treatment con-
dition. Blinding is facilitated by the fact that participants
complete identical assessment measures regardless of their
assigned condition throughout the course of the study.
This removes any need for research assistants to be in-
formed about participants’ randomization outcome.
Therapy commences thereafter, and therapy sessions
last approximately 60 minutes. Figure 2 provides a flow
diagram of study procedures from recruitment to
randomization.
Therapists and research staff
Therapists for the proposed project are postbaccalaure-
ate research assistants and graduate students with native
fluency in Spanish (n = 6). Given the differing degrees of
clinical training among the therapists, randomization
across conditions takes place to control for therapist ef-
fects. Treatment integrity and fidelity is ensured through
extensive therapist training and supervision. As training,
therapists completed six, 2-hour workshops conducted
by the BATD developer. They also attend 2 hours of on-
going weekly supervision with two doctoral level psy-
chologists, including the treatment developer (CWL)
and a second co-author (LM). During these supervisions
all therapy cases are discussed. Further, therapists attend
a 1-hour weekly supervision meeting in Spanish with the
first and second authors (AC and KEL). Goals of super-
vision include ensuring BATD and SC treatment fidelity
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and challenges encountered at each session. Treatment
fidelity strategies for monitoring and improving pro-
vider training procedures outlined by the National Insti-
tutes of Health Behavior Change Consortium [47] are
followed.
For the purpose of supervision, therapy sessions are
audiotaped with the permission of participants. Spanish-
speaking research assistants review 20% of audiore-
corded sessions to determine treatment adherence and
fidelity within 1 week of the therapy session using separ-
ate rating checklists and scales developed for the SC and
BATD conditions. Any treatment divergence is brought
up with the respective therapist and is discussed during
supervision meetings.
Overview of treatments
Behavioral activation treatment for depression
We are using the most current version of the Spanish
BATD manual [26] for this trial. As outlined in the man-
ual, the first session of BATD focuses on providing psy-
choeducation about depression, reviewing the treatment
rationale, discussing the importance of monitoring daily
activities, describing session attendance policies and
stressing the importance of attending every session
weekly, and explaining the relationship between treat-
ment adherence and the likelihood of treatment success.
Starting in the first session and continuing until the end
of treatment, the homework assignment focuses on par-
ticipants monitoring their daily activities until the subse-
quent session and reporting a numerical rating of both
enjoyment and importance for each activity completed.
The second BATD session consists of briefly reviewing
the content of the previous session, discussing activities
completed as well as the ratings of enjoyment and im-
portance, making use of the completed daily monitoring
record forms, and assessing any difficulties associated
with homework completion. The remainder of the sec-
ond session is devoted to a thorough discussion of life
areas (for example, relationships) and corresponding
values (for example, be a caring husband) important for
participants, with the purpose of selecting activities con-
sistent with these values in future sessions (for example,
taking spouse on monthly dates).
During the third session, participants work on select-
ing at least fifteen activities that they consider rewarding
(taking into consideration both expected enjoyment and
importance) that are consistent with life areas they deem
important and their expressed personal values. These
could constitute activities that are already a part of the
participants’ schedule or new activities. Participants rank
the activities in terms of difficulty. They complete easier
activities toward the beginning of treatment and progress
toward more challenging activities. During sessions 4through 10, participants work toward accomplishing three
to five activities on their list that reflect their values.
During session 5, participants are introduced to “con-
tracts”, which provides the opportunity to request assist-
ance from friends and family. Participants use contracts
in order to ask for help with accomplishing selected ac-
tivities that are challenging or that may be more “enjoy-
able” and “important” with company. No new material is
introduced beyond this point. Sessions 6 through 10
consist of continued engagement in meaningful activities
and daily monitoring, as well as discussions of an indi-
vidualized post-treatment plan within a behavioral acti-
vation framework of scheduling activities corresponding
to participants’ values and drafting “contracts” with
people in their support network. Throughout treatment,
depressogenic and non-depressogenic patterns are iden-
tified with the assistance of the monitoring forms and
ratings of enjoyment and importance.
Supportive counseling
To control for the non-specific elements of therapist con-
tact, approximately 30 clients are randomized to receive
SC. The SC manual used for the current study is modeled
after Novalis and colleagues [48]. The rationale of SC is
that depressed clients may benefit from sharing their
feelings, thoughts, and/or experiences in order to relieve
some of their emotional burden. This relief is facilitated
by the therapist’s provision of a supportive, non-
judgmental, and confidential environment. The oppor-
tunity to release emotional burden is consistent with
some reports that suggest that Latinos tend to expect
therapy to provide the opportunity for “desahogo” (that
is, to get things off one’s chest) [49]. Focus groups with
Latino clients have also described this treatment expect-
ation [15]. The rationale for SC is particularly relevant
for Latino immigrants, who may lack support in the US
and whose LEP may prevent establishing new connections.
SC does not follow a specific theoretical model and is
best described as offering the client unconditional sup-
port. The discussion for each session is patient-driven,
and the manual includes training in therapy using SC
techniques including reflections, empathic listening, en-
couragement, and help in exploration and expression of
feelings and experiences, without advice giving, solution
offering or skills teaching. Each SC session concludes
with a scripted relaxation exercise. The manual is orga-
nized in a way that reviews the basis for supportive psy-
chotherapy, the meaning of establishing a supportive
relationship, steps for beginning the therapy session, ses-
sion management, crisis management, and ethical factors
in supportive psychotherapy. Therapists are trained in
these procedures, in using non-directive techniques and
in avoiding BATD techniques. These topics are covered
in different chapters within the manual.
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work forms. The amount of homework assigned in the
SC condition is matched with BATD. Participants are
asked to write in the journal forms once a day about any
topic that they would like.
Assessments
In line with our study aims, participants complete ques-
tionnaires to assess five principal domains. Table 1 offers
a summary of the questionnaires, the domain they as-
sess, and the time-point at which they are administered.
Domain 1 - participant characteristics A standard
demographics questionnaire assesses participants’ educa-
tion, income, years of residence in the US, depression
treatment history, immigration status, and reason(s) for
immigrating (if applicable).
The Multidimensional Acculturative Stress Inventory
[50] was originally created to measure acculturative
stress from living in the US for individuals of Mexican
origin; the scale is comprised of four subscales including
English competency pressures (7 items), pressure to ac-
culturate (7 items), pressure against acculturation (4 items),
and Spanish competency pressures (7 items). Given the
non-applicability of the last subscale for the current
sample, we will only use the first three subscales. Higher
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Hamilton Rating Scale
for Depression
X X X X X
Domain 3: behavioral activation and reinforcement derived from the environ
Behavioral Activation for
Depression Scale
X X X X X
Reward probability
index
X X X X X
Domain 5: attitudes toward treatment
Stigma checklist X X
Therapeutic alliance X X
Treatment satisfaction X X
SCID-IV, Structured Clinical Interview for the Diagnostic Statistical Manual version IVthe questionnaire has achieved Cronbach alpha values
ranging from 0.74 to 0.91.
To determine study eligibility and the potential effect
of pharmacotherapy or other medications on the results
of the treatment, we collect information on participants’
medication use, including the names of medications and
length of use. Participants are excluded from the study if
they report taking medication but do not demonstrate
psychotropic stability as indicated by 3 or more months
of consistent use.
Domain 2 - depressive symptomatology To identify
depressive mood variations through the study trial, we
utilize the Beck Depression Inventory (BDI)-II [51]. The
inventory consists of 21 items that assess severity of de-
pressive symptomatology. BDI cumulative scores range
between 0 and 63; scores ranging between 14 and 19 are
indicative of mild depression, scores between 20 and 28
are indicative of moderate depression, and scores of 29
or above are indicative of severe depression. The Spanish
version of the BDI-II was developed by Sanz and col-
leagues [52] and was evaluated with a sample of 470
Spanish community adults.
The Hamilton Rating Scale for Depression (HRSD)
[53] is used as a clinician assessment of depressive symp-
tom severity. It is administered weekly in accordance with
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pertaining to libido, energy, weight, and appetite changes.
Scores are combined into a single total score, and the
measure has been shown to have strong divergent/conver-
gent validity and reliability. The psychometric properties
of the Spanish version of the HRSD have been investigated
in two studies [55,56] in which it demonstrated acceptable
internal consistency (0.72), good inter-rater reliability
(0.99), and good split-half reliability (0.89).
Additionally, to establish an MDD diagnosis and evalu-
ate remission rates, we administer the SCID-IV [46]. For
the current study, specific modules of the SCID-IV are
used to assess for: 1) primary affective disorders, including
major depression and manic episodes; 2) substance use
disorders, including abuse and dependence; 3) primary
anxiety disorders, including panic disorder, generalized
anxiety disorder, and post-traumatic stress disorder; and
4) and psychotic symptoms.
In the case that participants report intent to harm
themselves, we administer the Modified Scale for Sui-
cidal Ideation (MSSI) [57]. The questionnaire consists of
a semi-structured interview comprised of 18 items that
assess suicidal thoughts or behaviors over the past 2 days.
The questionnaire contains items related to suicide in-
tent, plan, and means as well as desire and reasons to
live or die. Each item is scored from 0 to 3, with higher
numbers indicating higher risk. The scale is only admin-
istered as needed. The MSSI was translated to Spanish
for the initial pilot study [32] to assess for severity of
suicidal ideation. Please see the 'Protection of Partici-
pants' section below for more details on the use of this
measure in the present study.
Domain 3 - behavioral activation and reinforcement/
punishment derived from the environment We are
utilizing two different measures of activation in our
study given purported differences between the con-
structs they are intended to assess: the Behavioral Acti-
vation for Depression Scale (BADS) [58] and the Reward
Probability Index (RPI) [59].
BADS consists of 25 items and was designed to meas-
ure the extent to which individuals become more acti-
vated and less avoidant through the course of the BA
intervention. The measure includes four subscales: acti-
vation, avoidance/rumination, work/school impairment,
and social impairment. Given that examining partici-
pants’ activation levels throughout the treatment course
is highly relevant to our study hypotheses, we will exam-
ine increases in the total BADS scale as well as in the
BADS activation subscale specifically. The activation
subscale contains items related to the engagement in fo-
cused, goal-directed activities as well as to the comple-
tion of scheduled activities [60] which allows examining
activation changes while isolating impairment elicited byavoidance or rumination (also measured within the
BADS). Items comprising this subscale include “I am
content with the amount and types of things I did” and
“I engaged in a wide and diverse array of activities”. The
internal consistency of the Spanish version of the
complete BADS scale has been reported at 0.80, and at
0.81 for the BADS activation subscale when adminis-
tered to a sample comprised of students at a Spanish
university [60].
The RPI is a 20-item scale that was developed to as-
sess availability of reinforcement in the environment.
The total RPI consists of two subscales: 1) the reward
probability index, which includes items measuring the
likelihood that individuals are able to obtain reinforcement
through instrumental behaviors; and 2) the environmental
suppressors index, which includes items that describe the
presence of aversive and unpleasant experiences in the re-
spondents’ environment [59]. Total RPI score is calculated
by adding scores of the items measuring reward probability
index with reversed scores of the items measuring environ-
mental suppressors. Internal consistency of the total RPI
scale was α = 0.90 and the test-retest reliability was r = 0.69
in the original validation study [59]. Because there is no
psychometric evaluation of a Spanish translation of the RPI,
the team that translated the original BATD treatment into
Spanish also translated this assessment tool. AC was re-
sponsible for back-translating the items into English (please
see [61] for more information about this procedure). Dis-
crepancies between the back-translation and the original
version of the questionnaire were discussed among the par-
ties and addressed. In the original validation study [60], psy-
chometric properties of each subscale suggested a strong
internal consistency (α = 0.82 to 0.90) as well as strong test-
retest reliability (r = 0.83 to 0.86) [59]. In the preliminary
study conducted by Collado and colleagues [32], the Cron-
bach’s alpha for the Spanish translation of the total RPI
scale ranged between 0.83 and 0.89. Further, Cronbach’s
alpha for the reward probability index subscale ranged be-
tween 0.84 and 0.95, and between 0.73 and 0.88 for the en-
vironmental suppressors index subscale across sessions,
indicating strong levels of internal consistency.
Domain 4 - treatment adherence Session attendance is
logged for every client. In addition, we will calculate
homework completion for each client by dividing the
total number of completed homework sessions by the
total number of assigned homework sessions.
Domain 5 - treatment correlates To measure stigma-
related concerns associated with receiving treatment for
depression, participants complete the Stigma Checklist
Questionnaire [62], a measure specifically designed for use
with low-income Spanish-speaking or bilingual Latino pa-
tients. The questionnaire consists of 7 items designed to
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pression and take medication, as well as their fear of rela-
tives learning that they are dealing with depression. The
reliability of the scale has been reported at a Cronbach’s
alpha of 0.69.
The Therapeutic Alliance with Clinician Questionnaire
[63] assesses the strength of the therapeutic relationship
using a 9-item Likert scale format. The Spanish version
of the questionnaire [64] was evaluated with a sample
predominantly comprised of depressed individuals and
achieved high internal consistency (α = 0.96) and an item
component correlation of 0.70. The authors concluded
that the measure has both clinical and research utility.
To elicit feedback about both treatment conditions, we
administer an in-house developed questionnaire every
other session. Participants rate the treatments on a 0 to
5 Likert-type scale across 10 items including “to what
extent do you believe that this treatment has improved
your depression/low mood?”, and “how valuable do you
think this treatment would be for individuals who ex-
perience depressed/low mood?” This treatment satisfac-
tion scale ranges from 0 to 50, with higher scores
representing higher satisfaction.
Protection of participants
Given that a diagnosis of MDD is a criterion for eligibil-
ity, participants’ safety and privacy throughout the
course of the study is a priority. Accordingly, we have
incorporated a Data Safety Monitoring Board (DSMB)
and a detailed safety protocol. The DSMB was created to
monitor and ensure participants’ safety through the
course of treatment. Members of the DSMB include five
independent researchers who have extensive experience
in treatment research with BATD and depression treat-
ment research in general. These individuals are involved
in the project as DSMB members in order to guarantee
objectivity regarding participants’ safety, study conduct,
and recommendations concerning the continuation or
modification of the project’s safety protocol. These
members participate in an annual teleconference to con-
duct continuous evaluation of the clients’ safety protocol.
In addition, monthly reports regarding clients’ progress
in both treatment conditions are generated. Any poten-
tial issues that pose risk to participants (during screening
or during the study course) are discussed over the tele-
phone with the DSMB.
For immediate crisis intervention, we developed a
thorough safety protocol. Every research assistant and
therapist involved in the study is trained in these proce-
dures following already established protocols for depres-
sion treatment development projects conducted at the
laboratory. In the case that a participant reports suicidal
intent and a plan, research assistants administer the
MSSI [57]. Prior to administering the MSSI, the researchassistant notifies the authors involved in the study. Im-
mediately after conducting the MSSI, the research assist-
ant informs the participant’s therapist of the results. The
therapist engages in an honest discussion with the par-
ticipant about his or her likelihood of carrying out sui-
cide. The therapist conducts a lethality risk assessment
and draws a contract with the participant indicating that
he or she will not make any attempts to carry out the
plans. The therapist and research assistant document the
outcome of the discussion and their impressions. The
appropriate authorities are notified if the participant is
perceived to be in imminent danger (in or out of
session).
Within 24 hours of conducting a safety protocol, a
conference call discussing relevant details takes place
with all of the DSMB members. The goal of this discus-
sion is for DSMB members to provide a future plan to
ensure the participant’s safety. A similar protocol is
followed in the case that a participant reports suicidal
ideation to his or her therapist. In that case, the MSSI is
not administered; rather a lethality risk assessment is
given primary emphasis. All other procedures are then
followed as described above.
Sample size considerations
We based our sample size needs on effects observed in
the literature, including other treatment studies, and by
making informed decisions about the magnitude of ef-
fects of BATD in this population that would likely be of
clinical significance. For the primary hypothesis that
BATD would result in greater reductions in depressive
symptoms, we calculated the sample size required based
on a recent meta-analysis conducted that examined the
effect size of BA relative to control conditions [29] and
on a treatment study that compared cognitive behavioral
therapy to an active treatment condition (interpersonal
psychotherapy) conducted by Rosselló and colleagues
[65] in a Spanish-speaking Latino sample. These studies
yielded effect sizes of 0.43 and 0.74, respectively, indicat-
ing medium to large effects. Our proposed sample size
of 30 in each cell fits well within that suggested by a
power analysis using these two reported effect sizes to
allow for a power of 0.80 using an alpha of 0.05 [66].
Our sample size also follows recommendations of in-
cluding 15 to 30 subjects per cell in this stage of treat-
ment development [67].
Data analysis plan
We will first assess equivalence of random assignment
of groups, patterns of missing data, research dropout
rates, and distributional properties of all measures. Hier-
archical linear modeling (HLM) [68] will be used to
examine within-subject change of depression (first aim)
and activation and reinforcement derived from the
Collado et al. Trials 2014, 15:231 Page 9 of 11
http://www.trialsjournal.com/content/15/1/231environment (second aim) over the course of treatment.
The nature of HLM analyses allows us to control for
baseline scores of each measure, include multiple meas-
urement points while accommodating missing data,
examine individual change over time in outcomes, and
include the average change and the individual variation
around this average change. We will specify all of our
HLM level-1 intercepts and slopes as random, given that
we expect first session depressive symptomatology,
activation, and availability of reinforcement in the envir-
onment, as well as each individual’s slope of these con-
structs, to differ across our participants. We will center
all variables of interest around the mean of respective
scores to avoid multicollinearity. Planned covariates in
these analyses will include gender, recruitment method,
and baseline levels of depressive symptoms, as well as
the main effect of treatment condition and the linear ef-
fect of time. Inclusion of the time by treatment condi-
tion interaction will indicate the extent to which
treatment differences are more or less pronounced early
versus later across treatment sessions. Categorical rates
of remission of MDD will be examined across treatment
conditions using the Cochran-Mantel-Haenszel test,
controlling for gender.
To examine the correspondence between increases in
activation and environmental reinforcement with de-
pression, we will also use HLM to examine correspond-
ence of these variables over time. These models will
include the aforementioned covariates in addition to in-
cluding activation and environmental reinforcement as
time-varying predictors of depression, the main effect of
treatment condition, the linear effect of time, and the in-
clusion of time by treatment condition interaction. Be-
cause of the difficulty in attributing causality between
variables assessed at the same time-point, we will also
conduct analyses predicting depression with environ-
mental reinforcement and activation assessed at the pre-
vious time-point as time-varying covariates (please see
Figure 1 depicting the lagged and concurrent analyses).
These lagged analyses will indicate whether the predictors
predict change in depression at subsequent assessments,
consistent with the BATD framework that activation and
environmental reinforcement are expected to increase be-
fore depression decreases.
To examine more closely the effects of treatment on
attendance, we will conduct a Cox proportional hazards
survival analysis predicting days to attrition. This will
allow us to examine the extent to which BATD was able
to increase the latency to treatment attrition. Homework
completion will be assessed by dividing the total number
of completed homework sessions by the total number of
assigned homework sessions for each participant. We
will conduct t-tests to examine differences in homework
completion between BATD and SC.Finally, we will conduct t-tests examining differences
between BATD and SC in treatment satisfaction, thera-
peutic alliance, and perceived stigma at each session
these correlates were examined.
Discussion
The current study is an RCT of 60 depressed Latinos with
LEP in the community randomized to BATD (n = 30) or
to SC (n = 30). Strengths of the trial involve a contact
time-matched control and the utilization of MDD as in-
clusion criteria rather than elevated depressive symptom-
atology. Another important aspect of the study is that, in
comparison to other treatment trials among Latinos, the
current study is utilizing a direct, Spanish translation of
the BATD manual without a priori cultural modifications.
Similar to the open-label trial, we made this decision be-
cause BATD facilitates treatment customization for each
client. Therefore, throughout treatment, the therapist em-
phasizes only values that are important to the client with-
out prior assumptions about their culture.
We also foresee specific study limitations. First, given
that the current study is being conducted as part of a
small, pre-doctoral grant, funds are limited for recruit-
ment in mass media, limiting the reach of our efforts. In
addition, we may observe a high dropout rate in this
study, consistent with trends in treatment development
studies with this population [16,17]. Given that our sam-
ple is already small, small but significant differences be-
tween the treatments may go undetected (type II error).
However, this concern is mitigated given the important
information that may be gained through the study,
including the efficacy of the two therapies tested, the
proposed mechanisms of change, and the treatment cor-
relates examined. Another limitation is the high rates of
comorbid psychopathology we may observe in our sam-
ple. This would be consistent with previous literature in
this particular population and our observations from the
BATD open-label trial. Although we believe that this
fosters external validity of our results in the context of
an RCT, it may also result in decreased overall treatment
gains [69].
To our knowledge, this constitutes the first effort to-
wards conducting an RCT comparing a behavioral inter-
vention to SC with a sample of depressed Spanish-
speaking Latinos in the US with LEP. This group has
been historically under-represented in both clinical and
research samples [70,71], which has prevented drawing
conclusions about the efficacy of psychotherapeutic
treatments for depression for this population. Together,
the increasing Latino with LEP population, the elevated
MDD rates among Latinos with LEP, high attrition rates,
and suboptimal treatment gains reported in previous de-
pression treatment studies, make the evaluation of BATD
in this group a pressing need. Therefore, the proposed
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needed evidence base, but it will also set the stage for a
larger RCT. Larger RCT studies may be able to incorpor-
ate standard of care treatments in addition to make pos-
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